Australia markets open in 6 hours 46 minutes

Palla Pharma Limited (PAL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.29500.0000 (0.00%)
At close: 03:10PM AEST

Palla Pharma Limited

Tower 4
727 Collins Street
Melbourne, VIC 3008
61 3 9301 0800

Sector(s):Β Consumer Defensive
Industry:Β Farm Products
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Mr. Jarrod David Ritchie B.Sc., BSc (Hons)Advisor839.35kN/AN/A
Mr. Giles MossChief Exec. OfficerN/AN/AN/A
Mr. Paul A. Sherman B.Bus, C.A., CA, M.B.A., MBAChief Financial OfficerN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

Corporate governance

Palla Pharma Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.